Literature DB >> 17028824

HLA-B52-positive vasculo-Behçet disease: usefulness of magnetic resonance angiography, ultrasound study, and computed tomographic angiography for the early evaluation of multiarterial lesions.

Kota Sugisaki1, Rie Saito, Tadayuki Takagi, Kiori Shio, Yasuo Shioya, Etsuko Fukaya, Haruyo Iwadate, Hideharu Sekine, Hiroshi Orikasa, Hiroko Kobayashi, Hiroshi Watanabe, Yukio Sato.   

Abstract

We report a case of HLA-B52-positive Behçet disease accompanied by multiarterial lesions. A 24-year-old woman was suffering from sporadic high fever and recurrent oral and genital ulcers, and laboratory data revealed severe inflammation. A diagnosis of Behçet disease was made. Magnetic resonance angiography, ultrasound study, and computed tomographic angiography demonstrated multiarterial lesions that had caused no symptoms. These noninvasive examinations were extremely useful in evaluating asymptomatic early vascular lesions.

Entities:  

Year:  2005        PMID: 17028824     DOI: 10.1007/s10165-004-0356-8

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  4 in total

Review 1.  Role of Human Leukocyte Antigens (HLA) in Autoimmune Diseases.

Authors:  Gergely Bodis; Victoria Toth; Andreas Schwarting
Journal:  Rheumatol Ther       Date:  2018-03-07

2.  The Immunogenetics of Behcet's Disease.

Authors:  Mustafa Anıl Yılmaz; Ümit Türsen
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 3.  Aortic Regurgitation Presenting with Recurrent Detachment of a Prosthetic Valve, as the First Presenting Symptom of Cardiovascular Behçet's Disease.

Authors:  Tsugumi Takayama; Takuya Ozawa; Akiko Sanada; Tohru Watanabe; Masahiro Ito; Satoru Hirono; Yoshifusa Aizawa; Tohru Minamino
Journal:  Intern Med       Date:  2017-12-08       Impact factor: 1.271

4.  Retinal vasculitis and skin ulcer preceding Budd-Chiari syndrome in a patient with Behcet's disease.

Authors:  Priyavrat Bhatia; Alok Sen; Gaurav Mohan Kohli; Pratik Shenoy
Journal:  Indian J Ophthalmol       Date:  2020-09       Impact factor: 1.848

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.